{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:40:02Z","timestamp":1785908402046,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13346-021-00919-4","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T17:02:58Z","timestamp":1611939778000},"page":"647-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans"],"prefix":"10.1007","volume":"11","author":[{"given":"Ana L.","family":"Mart\u00ednez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Gonz\u00e1lez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Vizmanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9687-3436","authenticated-orcid":false,"given":"Juan M.","family":"Irache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"919_CR1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1126\/science.6337396","volume":"219","author":"IS Johnson","year":"1983","unstructured":"Johnson IS. Human insulin from recombinant DNA technology. Science. 1983;219:632\u20137.","journal-title":"Science"},{"issue":"7","key":"919_CR2","doi-asserted-by":"publisher","first-page":"e0181748","DOI":"10.1371\/journal.pone.0181748","volume":"12","author":"SS Usmani","year":"2017","unstructured":"Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, Ahuja AA, Sharma M, Gautam A, Raghava GPS. THPdb: Database of FDA-approved peptide and protein therapeutics. PLoS ONE. 2017;12(7):e0181748. https:\/\/doi.org\/10.1371\/journal.pone.0181748.","journal-title":"PLoS ONE"},{"issue":"10","key":"919_CR3","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","volume":"26","author":"JL Lau","year":"2018","unstructured":"Lau JL, Dunn MK. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorg Med Chem. 2018;26(10):2700\u20137. https:\/\/doi.org\/10.1016\/j.bmc.2017.06.052.","journal-title":"Bioorg Med Chem"},{"key":"919_CR4","unstructured":"Peptide Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019\u20132027 [Internet]. Transpar Mark Res. 2020. Available from: https:\/\/www.transparencymarketresearch.com\/peptide-therapeutics-market.html"},{"issue":"1","key":"919_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","volume":"20","author":"K Fosgerau","year":"2015","unstructured":"Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015;20(1):122\u20138. https:\/\/doi.org\/10.1016\/j.drudis.2014.10.003.","journal-title":"Drug Discov Today"},{"key":"919_CR6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.biopha.2018.04.025","volume":"103","author":"MH Baig","year":"2018","unstructured":"Baig MH, Ahmad K, Saeed M, Alharbi AM, Barreto GE, Ashraf GM, Choi I. Biomed Pharmacother. 2018;103:574\u201381. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.025.","journal-title":"Biomed Pharmacother"},{"key":"919_CR7","first-page":"1552","volume":"11","author":"NS Chauhan","year":"2010","unstructured":"Chauhan NS, Chauhan Nitesh S, Sanjeev C, Vandana H, Alka A, Vijender S. Recent Advances in Insulin Delivery Systems: An Update. World Appl Sci J. 2010;11:1552\u20136.","journal-title":"World Appl Sci J"},{"issue":"15","key":"919_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.addr.2007.08.019","volume":"59","author":"ES Khafagy","year":"2007","unstructured":"Khafagy ES, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev. 2007;59(15):1521\u201346. https:\/\/doi.org\/10.1016\/j.addr.2007.08.019.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"919_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pmr.2007.10.010","volume":"19","author":"JA Tracy","year":"2008","unstructured":"Tracy JA, Dyck PJB. The spectrum of diabetic neuropathies. Phys Med Rehabil Clin N Am. 2008;19(1):1\u201326. https:\/\/doi.org\/10.1016\/j.pmr.2007.10.010.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"6","key":"919_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","volume":"64","author":"LM Ensign","year":"2012","unstructured":"Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64(6):557\u201370. https:\/\/doi.org\/10.1016\/j.addr.2011.12.009.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"919_CR11","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.4155\/tde.13.104","volume":"4","author":"BJ Bruno","year":"2013","unstructured":"Bruno BJ, Miller GD, Lim CS. Basics and recent advances in peptide and protein drug delivery. Ther Deliv. 2013;4(11):1443\u201367. https:\/\/doi.org\/10.4155\/tde.13.104.","journal-title":"Ther Deliv"},{"key":"919_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jconrel.2014.09.031","volume":"196","author":"VK Pawar","year":"2014","unstructured":"Pawar VK, Meher JG, Singh Y, Chaurasia M, Surendar Reddy B, Chourasia MK. Targeting of gastrointestinal tract for amended delivery of protein\/peptide therapeutics: Strategies and industrial perspectives. J Control Release. 2014;196:168\u201383. https:\/\/doi.org\/10.1016\/j.jconrel.2014.09.031.","journal-title":"J Control Release"},{"issue":"2","key":"919_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0168-3659(01)00218-8","volume":"71","author":"YP Li","year":"2001","unstructured":"Li YP, Pei YY, Zhang XY, Gu ZH, Zhou ZH, Yuan W-F, Zhou J, Zhu J, Gao X. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release. 2001;71(2):203\u201311. https:\/\/doi.org\/10.1016\/s0168-3659(01)00218-8.","journal-title":"J Control Release"},{"issue":"Pt A","key":"919_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejpb.2014.12.021","volume":"97","author":"L Inchaurraga","year":"2015","unstructured":"Inchaurraga L, Mart\u00edn-Arbella N, Zabaleta V, Quincoces G, Pe\u00f1uelas I, Irache JM. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration. Eur J Pharm Biopharm. 2015;97(Pt A):280\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2014.12.021.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"919_CR15","doi-asserted-by":"publisher","first-page":"e1601556","DOI":"10.1126\/sciadv.1601556","volume":"3","author":"CS Schneider","year":"2017","unstructured":"Schneider CS, Xu Q, Boylan NJ, Chisholm J, Tang BC, Schuster BS, Henning A, Ensign LM, Lee E, Adstamongkonkul P, Simons BW, Wang S-YS, Gong X, Yu T, Boyle MP, Suk JS, Hanes J. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation. Sci Adv. 2017;3(4):e1601556. https:\/\/doi.org\/10.1126\/sciadv.1601556.","journal-title":"Sci Adv"},{"key":"919_CR16","doi-asserted-by":"publisher","first-page":"119289","DOI":"10.1016\/j.ijpharm.2020.119289","volume":"581","author":"AL Mart\u00ednez-L\u00f3pez","year":"2020","unstructured":"Mart\u00ednez-L\u00f3pez AL, Pangua C, Reboredo C, Campi\u00f3n R, Morales-Gracia J, Irache JM. Protein-based nanoparticles for drug delivery purposes. Int J Pharm. 2020;581:119289. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119289.","journal-title":"Int J Pharm"},{"key":"919_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jddst.2015.06.012","volume":"30","author":"R Pe\u00f1alva","year":"2015","unstructured":"Pe\u00f1alva R, Esparza I, Gonz\u00e1lez-Navarro CJ, Quincoces G, Pe\u00f1uelas I, Irache JM. Zein nanoparticles for oral folic acid delivery. J Drug Deliv Sci Technol. 2015;30:450\u20137.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"919_CR18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s13346-020-00796-3","volume":"10","author":"L Inchaurraga","year":"2020","unstructured":"Inchaurraga L, Mart\u00ednez-L\u00f3pez AL, Martin-Arbella N, Irache JM. Zein-based nanoparticles for the oral delivery of insulin. Drug Deliv Transl Res. 2020;10(6):1601\u201311. https:\/\/doi.org\/10.1007\/s13346-020-00796-3.","journal-title":"Drug Deliv Transl Res"},{"key":"919_CR19","doi-asserted-by":"publisher","first-page":"118699","DOI":"10.1016\/j.ijpharm.2019.118699","volume":"571","author":"L Ruiz-Gat\u00f3n","year":"2019","unstructured":"Ruiz-Gat\u00f3n L, Espuelas S, Huarte J, Larra\u00f1eta E, Martin-Arbella N, Irache JM. Nanoparticles from Gantrez\u00ae AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel. Int J Pharm. 2019;571:118699. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118699.","journal-title":"Int J Pharm"},{"issue":"5","key":"919_CR20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ejps.2011.12.016","volume":"45","author":"S Doktorovova","year":"2012","unstructured":"Doktorovova S, Shegokar R, Martins-Lopes P, Silva AM, Lopes CM, M\u00fcller RH, Souto EB. Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN). Eur J Pharm Sci Elsevier. 2012;45(5):606\u201312. https:\/\/doi.org\/10.1016\/j.ejps.2011.12.016.","journal-title":"Eur J Pharm Sci Elsevier"},{"key":"919_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejpb.2015.01.023","volume":"97","author":"M Abdulkarim","year":"2015","unstructured":"Abdulkarim M, Agull\u00f3 N, Cattoz B, Griffiths P, Bernkop-Schn\u00fcrch A, Borros SG, Gumbleton M. Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles. Eur J Pharm Biopharm. 2015;97:230\u20138. https:\/\/doi.org\/10.1016\/j.ejpb.2015.01.023.","journal-title":"Eur J Pharm Biopharm"},{"key":"919_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejps.2018.11.025","volume":"128","author":"L Inchaurraga","year":"2019","unstructured":"Inchaurraga L, Mart\u00ednez-L\u00f3pez AL, Cattoz B, Gri PC, Wilcox M, Pearson P, Quincoces G, Pe\u00f1uelas I, Martin-Arbella N, Irache JM. The effect of thiamine-coating nanoparticles on their biodistribution and fate following oral administration. Eur J Pharm Sci. 2019;128:81\u201390. https:\/\/doi.org\/10.1016\/j.ejps.2018.11.025.","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"919_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Stephan Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. Fiji: An open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382. https:\/\/doi.org\/10.1038\/nmeth.2019.","journal-title":"Nat Methods"},{"issue":"1","key":"919_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/genetics\/77.1.71","volume":"77","author":"S Brenner","year":"1974","unstructured":"Brenner S. The genetics of Caenorabditis elegans. Genetics. 1974;77(1):71\u201394.","journal-title":"Genetics"},{"key":"919_CR25","doi-asserted-by":"publisher","unstructured":"Navarro-Herrera D, Aranaz P, Eder-Azanza L, Zabala M, Hurtado C, Romo-Hualde A, Mart\u00ednez JA, Gonz\u00e1lez-Navarro CJ, Vizmanos JL. Dihomo-gamma-linolenic acid induces fat loss in: C. elegans in an omega-3-independent manner by promoting peroxisomal fatty acid \u03b2-oxidation. Food Funct. 2018;9(3):1621\u20131637.\u00a0https:\/\/doi.org\/10.1039\/c7fo01625e.","DOI":"10.1039\/c7fo01625e"},{"key":"919_CR26","doi-asserted-by":"publisher","unstructured":"You Y, Kim J, Raizen DM, Avery L. Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: a model for satiety. Cell Metab. 2008;7(3):249\u201357.\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2008.01.005.27.","DOI":"10.1016\/j.cmet.2008.01.005.27"},{"issue":"3","key":"919_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/biof.1346","volume":"43","author":"P Shen","year":"2017","unstructured":"Shen P, Yue Y, Sun Q, Kasireddy N, Kim KH, Park Y. Piceatannol extends the lifespan of Caenorhabditis elegans via DAF-16. BioFactors. 2017;43(3):379\u201387. https:\/\/doi.org\/10.1002\/biof.1346.","journal-title":"BioFactors"},{"key":"919_CR28","doi-asserted-by":"publisher","unstructured":"Yu T, Wang Y, Yang M, Schneider C, Zhong W, Pulicare S, Choi WJ, Mert O, Fu J, Lai SK, Hanes J. Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic- co -glycolic acid). Drug Deliv Transl Res. 2012;2(2)\u00a0https:\/\/doi.org\/10.1007\/s13346-011-0048-9.","DOI":"10.1007\/s13346-011-0048-9"},{"key":"919_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.colsurfb.2015.07.038","volume":"135","author":"BH Bajka","year":"2015","unstructured":"Bajka BH, Rigby NM, Cross KL, Macierzanka A, Mackie AR. The influence of small intestinal mucus structure on particle transport ex vivo. Colloids Surf B Biointerfaces. 2015;135:73\u201380. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.07.038.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"9","key":"919_CR30","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1021\/acsnano.5b038762015;9:9217-27","volume":"9","author":"Q Xu","year":"2015","unstructured":"Xu Q, Ensign LM, Boylan NJ, Schon A, Gong X, Yang JC, Lamb NW, Cai S, Yu T, Freire E, Hanes J. Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo. ACS Nano. 2015;9(9):9217\u201327. https:\/\/doi.org\/10.1021\/acsnano.5b038762015;9:9217-27.","journal-title":"ACS Nano"},{"key":"919_CR31","doi-asserted-by":"publisher","unstructured":"Lee SJ, Murphy CT, Kenyon C. Glucose shortens the life span of C. elegans by Downregulating DAF-16\/FOXO Activity and Aquaporin Gene Expression. Cell Metab. 2009;10(5):379\u201391.\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2009.10.003.","DOI":"10.1016\/j.cmet.2009.10.003"},{"key":"919_CR32","first-page":"10554","volume":"10","author":"Z Lu","year":"2017","unstructured":"Lu Z, Qiu Z. High glucose concentration restricts fat consumption in Caenorhabditis elegans. Int J Clin Exp Med. 2017;10:10554\u20139.","journal-title":"Int J Clin Exp Med"},{"issue":"11","key":"919_CR33","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.2337\/db09-0567","volume":"58","author":"A Schlotterer","year":"2009","unstructured":"Schlotterer A, Kukudov G, Bozorgmehr F, Hutter H, Du X, Oikonomou D, Ibrahim Y, Pfisterer F, Rabbani N, Thornalley P, Sayed A, Fleming T, Humpert P, Schwenger V, Zeier M, Hamann A, Stern D, Brownlee M, Bierhaus A, Nawroth P, Morcos MC. elegans as model for the study of high glucose-mediated life span reduction. Diabetes. 2009;58(11):2450\u20136. https:\/\/doi.org\/10.2337\/db09-0567.","journal-title":"Diabetes"},{"issue":"4","key":"919_CR34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cmet.2007.08.011","volume":"6","author":"TJ Schulz","year":"2007","unstructured":"Schulz TJ, Zarse K, Voigt A, Urban N, Birringer M, Ristow M. Glucose restriction extends Caenorhabditis elegans life span by Inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 2007;6(4):280\u201393. https:\/\/doi.org\/10.1016\/j.cmet.2007.08.011.","journal-title":"Cell Metab"},{"key":"919_CR35","doi-asserted-by":"publisher","unstructured":"Zhu G, Yin F, Wang L, Wei W, Jiang L, Qin J. Modeling type 2 diabetes-like hyperglycemia in C. elegans on a microdevice. Integr Biol (Camb). 2016;8(1):30\u20138. https:\/\/doi.org\/10.1039\/c5ib00243e.","DOI":"10.1039\/c5ib00243e"},{"issue":"9","key":"919_CR36","doi-asserted-by":"publisher","first-page":"e12810","DOI":"10.1371\/journal.pone.0012810","volume":"5","author":"K Yen","year":"2010","unstructured":"Yen K, Le TT, Bansal A, Narasimhan SD, Cheng J, Heidi A. A Comparative Study of Fat Storage Quantitation in Nematode Caenorhabditis elegans Using Label and Label-Free Methods. PLoS ONE. 2010;5(9):e12810. https:\/\/doi.org\/10.1371\/journal.pone.0012810.","journal-title":"PLoS ONE"},{"issue":"1","key":"919_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12263-009-0157-y","volume":"5","author":"T Nomura","year":"2010","unstructured":"Nomura T, Horikawa M, Shimamura S, Hashimoto T, Sakamoto K. Fat accumulation in Caenorhabditis elegans is mediated by SREBP homolog SBP-1. Genes Nutr. 2010;5(1):17\u201327. https:\/\/doi.org\/10.1007\/s12263-009-0157-y.","journal-title":"Genes Nutr"},{"issue":"1","key":"919_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1534\/genetics.115.174631","volume":"200","author":"AM Garcia","year":"2015","unstructured":"Garcia AM, Ladage ML, Dumesnil DR, Zaman K, Shulaev V, Azad RK, et al. Glucose induces sensitivity to oxygen deprivation and modulates Insulin\/IGF-1 signaling and lipid biosynthesis in Caenorhabditis elegans. Genetics. 2015;200(1):167\u201384. https:\/\/doi.org\/10.1534\/genetics.115.174631.","journal-title":"Genetics"},{"key":"919_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00125-014-3415-5","volume":"58","author":"M Mendler","year":"2014","unstructured":"Mendler M, Schlotterer A, Ibrahim Y, Kukudov G, Fleming T, Bierhaus A, Padilla PA. daf-16\/FOXO and glod-4\/glyoxalase-1 are required for the life-prolonging effect of human insulin under high glucose conditions in Caenorhabditis elegans. Diabetologia. 2014;58:393\u2013401.","journal-title":"Diabetologia"},{"key":"919_CR40","doi-asserted-by":"publisher","unstructured":"Dimov I, Maduro MF. The C. elegans intestine: organogenesis, digestion, and physiology. Cell Tissue Res. 2019 Sep;377(3):383\u201396.\u00a0https:\/\/doi.org\/10.1007\/s00441-019-03036-4.","DOI":"10.1007\/s00441-019-03036-4"},{"issue":"10","key":"919_CR41","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1242\/bio.012260","volume":"4","author":"JL Everman","year":"2015","unstructured":"Everman JL, Ziaie NR, Bechler J, Bermudez LE. Establishing Caenorhabditis elegans as a model for Mycobacterium avium subspecies hominissuis infection and intestinal colonization. Biol Open. 2015;4(10):1330\u20135. https:\/\/doi.org\/10.1242\/bio.012260.","journal-title":"Biol Open"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00919-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-021-00919-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00919-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T15:10:51Z","timestamp":1616512251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-021-00919-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1007\/s13346-021-00919-4","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"19 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In vivo studies with invertebrates, such as\u00a0<i>Caenorhabditis elegans<\/i>, did not require\u00a0approval from the institution's animal care and usage committee (Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors consent for the publication of this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}